Auditor30 Oct 2026, 03:20 pm
Sun Pharma Appoints Deloitte Haskins & Sells as New Auditors
AI Summary
Sun Pharmaceutical Industries Limited announced the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as its new Statutory Auditors. This appointment follows the mandatory auditor rotation requirement, as the current auditors, S R B C & CO LLP, will complete their second consecutive five-year term at the conclusion of the AGM for the financial year 2026-27. Deloitte Haskins & Sells will serve for a term of five consecutive years, commencing from the conclusion of the AGM for FY2026-27 until the conclusion of the AGM for FY2031-32, subject to shareholder approval.
Key Highlights
- Deloitte Haskins & Sells appointed as new Statutory Auditors.
- Current auditors S R B C & CO LLP to complete tenure.
- Appointment is due to mandatory auditor rotation policy.
- New auditors appointed for a five-year term.
- Shareholder approval is required for the appointment.
Price Impact
More from SUNPHARMA